Zhi Lu

549 total citations
7 papers, 416 citations indexed

About

Zhi Lu is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Zhi Lu has authored 7 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Zhi Lu's work include Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers) and RNA modifications and cancer (2 papers). Zhi Lu is often cited by papers focused on Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers) and RNA modifications and cancer (2 papers). Zhi Lu collaborates with scholars based in China, Germany and Saudi Arabia. Zhi Lu's co-authors include Wei Zhao, Xiandong Zeng, Yong Wang, Ningning Wang, Xi Zhang, Yueyan Zhang, Lan Luan, Junjie Zhang, Yong Wang and Yiqun Yao and has published in prestigious journals such as Molecular Cancer, Cancer Science and Frontiers in Oncology.

In The Last Decade

Zhi Lu

7 papers receiving 412 citations

Peers

Zhi Lu
Kelin She China
Zheng Zhi China
Sen Meng China
Xiubo Lu China
Kelin She China
Zhi Lu
Citations per year, relative to Zhi Lu Zhi Lu (= 1×) peers Kelin She

Countries citing papers authored by Zhi Lu

Since Specialization
Citations

This map shows the geographic impact of Zhi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Lu more than expected).

Fields of papers citing papers by Zhi Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Lu. The network helps show where Zhi Lu may publish in the future.

Co-authorship network of co-authors of Zhi Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi Lu. A scholar is included among the top collaborators of Zhi Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi Lu. Zhi Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Yang, Li, Xue Gao, Lina Zhang, et al.. (2023). Disitamab Vedotin (RC48) for HER2-positive advanced breast cancer: a case report and literature review. Frontiers in Oncology. 13. 1286392–1286392. 3 indexed citations
2.
Lu, Zhi, et al.. (2021). Dioscin ameliorates diabetes cognitive dysfunction via adjusting P2X7R/NLRP3 signal. International Immunopharmacology. 101(Pt B). 108314–108314. 18 indexed citations
3.
4.
Wang, Yong, Zhi Lu, Junjie Zhang, et al.. (2018). Long noncoding RNA DANCR promotes colorectal cancer proliferation and metastasis via miR-577 sponging. Experimental & Molecular Medicine. 50(5). 1–17. 90 indexed citations
5.
Lu, Zhi, et al.. (2018). Long non‐coding RNA NEAT1 promoted ovarian cancer cells’ metastasis through regulation of miR‐382‐3p/ROCK1 axial. Cancer Science. 109(7). 2188–2198. 75 indexed citations
6.
Wang, Yong, et al.. (2017). MicroRNA-1299 is a negative regulator of STAT3 in colon cancer. Oncology Reports. 37(6). 3227–3234. 37 indexed citations
7.
Yuan, Xi, et al.. (1995). The establishment of two cell lines from a mouse uterine cervical carcinoma (U14) and their metastatic phenotype changes. Clinical & Experimental Metastasis. 13(6). 463–473. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026